In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...

At September 30, 2025, Edesa had cash and cash equivalents of $10.8 million and working capital of $10.4 million. Subsequent to the fiscal year end, the company received $3.4 million in net proceeds, ...

Zealand Pharma may be gearing up for a high-stakes year of obesity readouts, but the Danish biopharma thinks the brain could hold the key to the company’s long-term success. | Zealand Pharma may be ...

Detailed price information for Sana Biotechnology Inc (SANA-Q) from The Globe and Mail including charting and trades.

PharmAla is furthermore pleased to announce that it has completed its first delivery of its Australian-made product to the Orygen Institute. The shipment represents the second such shipment made by ...

Biotechnology is also a vital engine of economic prosperity, generating almost 7% of U.S. private-sector GDP and supporting roughly 10 million jobs across all 50 states. The good news is that we still ...

Close to two years after AbbVie handed over $48 million for the rights to OSE Immunotherapeutics’ inflammation drug, the Big ...

Citi Annual Global Healthcare Conference 2025 December 2, 2025 2:30 PM ESTCompany ParticipantsSteven Harr - President, ...

With new UK clinical trial rules landing in 2026, the EU Biotech Act on the horizon and China and Australia gaining ground, ...

With regulators across Asia-Pacific easing pathways for new therapies, Dimerix is positioning DMX-200 for one of the world’s ...

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...